Palisade Bio
PALI1.8953.32% ( -0.065 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Palisade Bio(PALI) predict that the EBIT is -10.75 M (-365.3%), Miss estimate;the EPS is -0.05 (+89.36%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.01B365.28%
-0.01B264.27%
-0.00B101.01%
EPSMiss expectations
-0.0589.36%
-0.0491.49%
-0.01002.13%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf